Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Debt to Equity (2021)

Whitehawk Therapeutics (WHWK) has disclosed Debt to Equity for 1 consecutive years, with $0.04 as the latest value for Q4 2021.

  • On a quarterly basis, Debt to Equity changed N/A to $0.04 in Q4 2021 year-over-year; TTM through Dec 2021 was $0.04, a N/A change, with the full-year FY2021 number at $0.04, changed N/A from a year prior.
  • Debt to Equity was $0.04 for Q4 2021 at Whitehawk Therapeutics, up from $0.04 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.04 in Q4 2021 to a low of $0.04 in Q3 2021.